양막 시장 규모, 점유율, 동향 분석 리포트 : 최종 용도별, 제품별, 용도별, 지역별, 부문별 예측(2024-2030년)

Amniotic Membrane Market Size, Share & Trends Analysis Report By End-use (Hospitals, Specialty Clinics), By Product, By Application, By Region, And Segment Forecasts, 2024 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

양막 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 양막 시장 규모는 2024-2030년 13.1%의 CAGR을 기록하며, 2030년에는 85억 달러에 달할 것으로 예측됩니다.

전 세계에서 외상 및 화상 환자 수 증가, 수술 증가, 양막 기반 제품이 제공하는 다양한 이점에 대한 인식 증가는 양막에 대한 수요를 증가시키는 요인입니다. 양막의 통증 완화 특성으로 인해 외과적 상처 및 안과에서 이러한 조직 기반 제품의 채택이 증가 할 수 있습니다.

또한 줄기세포 및 재생의료 분야의 연구개발비 증가와 수술 건수 증가도 시장 성장을 증가시킬 것으로 예상되는 주요 요인 중 하나입니다. 안과, 피부, 뇌, 두경부, 비뇨생식기, 기타 외과수술 등 다양한 제품에 적용되면서 세계 시장은 잠재력을 확보할 것으로 예상됩니다. 또한 전 세계에서 양막 이식이 증가하고 있는 것도 전체 시장 성장에 박차를 가할 것으로 예상됩니다. 또한 의료 종사자뿐만 아니라 개인들 사이에서도 제품의 이점에 대한 인식이 높아지면서 향후 수년간 수요가 증가할 것으로 예상됩니다.

그러나 숙련된 전문가 부족은 시장 성장에 걸림돌이 될 것으로 예상됩니다. 양막 기반 제품은 정맥 궤양, 욕창, 당뇨병성 족부 궤양, 안과, 수술, 만성 상처 관리 등 다양한 분야의 치료에 가장 많이 사용되고 있습니다. 또한 줄기세포 연구 및 재생의학 분야의 연구가 증가함에 따라 다양한 연구기관과 학술기관이 이러한 제품을 다른 용도로 사용하기 위한 연구에 참여하고 있습니다.

양막 시장 보고서의 하이라이트

• 냉동 보존 양막 부문은 2023년 50.0% 이상의 가장 큰 매출 점유율을 차지했습니다.
• 외과적 상처 분야는 외과적 시술 증가와 외과적 용도의 광범위한 제품 사용으로 인해 2023년 36.7%의 가장 큰 매출 점유율을 차지할 것으로 예상됩니다.
• 전 세계에서 미용 성형 및 재건 수술이 증가함에 따라 전문 클리닉이 2030년까지 가장 높은 시장 점유율을 차지할 것으로 예상됩니다.
• 북미는 다수의 대기업이 존재하고 만성질환 및 감염성 질환 유병률이 높아 2023년 매출 점유율이 31.7%로 시장을 장악했습니다.
• 아시아태평양은 인구 증가와 만성질환 및 화상 증가로 인해 예측 기간 중 14.5%의 연평균 복합 성장률(CAGR)로 급성장할 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 양막 시장 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 양막 시장 분석 툴
  • 업계 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 양막 시장 : 제품별 추정·동향 분석

• 부문 대시보드
• 양막 시장 : 제품별 변동 분석
• 양막 시장 : 제품별 전망
• 2018-2030년 시장 규모와 예측 및 동향 분석
• 동결 보존된 양막
• 탈수한 양막

제5장 양막 시장 : 용도별 추정·동향 분석

• 부문 대시보드
• 양막 시장 : 용도별 변동 분석
• 양막 시장의 용도별 전망
• 2018-2030년 시장 규모와 예측 및 동향 분석
• 수술창
• 안과
• 기타

제6장 양막 시장 : 최종 용도별 추정·동향 분석

• 부문 대시보드
• 양막 시장 : 최종 용도별 변동 분석
• 양막 시장의 최종 용도별 전망
• 2018-2030년 시장 규모와 예측 및 동향 분석
• 병원
• 외래 수술 센터
• 전문 클리닉
• 연구기관 및 학술기관

제7장 양막 시장 : 지역별 추정·동향 분석

• 지역 대시보드
• 지역별 양막 시장변수 분석
• 양막 시장 : 제품, 용도, 최종 용도별 지역 추정·동향 분석
• 2018-2030년 시장 규모와 예측 및 동향 분석
• 북미
  • 북미 양막 시장 추산·예측, 2018-2030년
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 유럽의 양막 시장 추산·예측, 2018-2030년
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 아시아태평양의 양막 시장 추산·예측, 2018-2030년
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 라틴아메리카의 양막 시장 추산·예측, 2018-2030년
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 중동 및 아프리카의 양막 시장 추산·예측, 2018-2030년
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제8장 경쟁 구도

• 시장 참여 기업의 분류
• 주요 기업 개요
  • Alliqua BioMedical Inc.
  • Amnio Technology, LLC.
  • Applied Biologics LLC
  • Human Regenerative Technologies, LLC
  • DermaSciences
  • Katena Products, Inc.
  • MiMedx Group Inc.
  • Skye Biologics, Inc.
  • Amniox Medical Inc.
  • Integra LifeSciences

KSA

영문 목차

영문목차

Amniotic Membrane Market Growth & Trends:

The global amniotic membrane market size is expected to reach USD 8.50 billion by 2030, registering a CAGR of 13.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Global rise in the number of trauma and burn cases, surgeries, and increasing cognizance regarding various benefits offered by amniotic membrane-based products are factors increasing their demand. Amniotic membrane has pain-reducing properties, which may lead to the increased adoption of these tissue-based products in surgical wounds and ophthalmology.

Also, rising expenditure in R&D in the field of stem cells and regenerative medicine and the rising number of surgeries being performed are some of the key factors anticipated to augment the market growth. The global market is expected to gain potential owing to a wide range of product applications in ophthalmology, skin, brain, and head & neck, genitourinary tract, as well as other surgical procedures. In addition, the rise in amniotic membrane-based transplantations across the globe is predicted to fuel the overall market growth. Moreover, rising awareness regarding the product benefits among healthcare professionals as well as individuals is estimated to boost the demand over the forecast years.

However, the dearth of skilled professionals is expected to impede market growth. Amniotic membrane-based products are most commonly used in the treatment of various areas, such as venous, pressure, and diabetic foot ulcers, ophthalmology, surgeries, and also in the management of chronic wounds. Moreover, with increasing research in the field of stem cell research and regenerative medicine, various research and academic institutes are engaged in a study to facilitate the usage of these products for other applications.

Amniotic Membrane Market Report Highlights:

• The cryopreserved amniotic membrane segment held the largest revenue share of more than 50.0% in 2023 owing to the high effectivity and preservation of histological and biological properties in these membranes
• The surgical wounds segment accounted for the maximum revenue share of 36.7% in 2023 due to the increased volume of surgical procedures and wide product usage in surgical applications
• Specialty clinics are anticipated to gain the highest market share by 2030 due to the increasing number of cosmetic and reconstructive surgeries being performed globally
• North America dominated the market in 2023 with a revenue share of 31.7% owing to the existence of a large number of major players and the high incidence of chronic and infectious diseases
• Asia Pacific is expected to grow at the fastest CAGR of 14.5% during the forecast period due to the high population coupled with the rising chronic diseases and burn incidences

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Product
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Product outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Amniotic Membrane Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising research on stem cell biology and regenerative medicine
    • 3.2.1.2. Increasing awareness towards benefits offered by amniotic membrane
    • 3.2.1.3. Rise in the number of accident and trauma cases
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Lack of skilled professionals
    • 3.2.2.2. Lack of standardized guidelines
• 3.3. Amniotic Membrane Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Amniotic Membrane Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Amniotic Membrane Market: Product Movement Analysis
• 4.3. Amniotic Membrane Market by Product Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Cryopreserved Amniotic Membrane
  • 4.5.1. Cryopreserved Amniotic Membrane Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Dehydrated Amniotic Membrane
  • 4.6.1. Dehydrated Amniotic Membrane Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Amniotic Membrane Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Amniotic Membrane Market: Application Movement Analysis
• 5.3. Amniotic Membrane Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Surgical Wounds
  • 5.5.1. Surgical Wounds Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Ophthalmology
  • 5.6.1. Ophthalmology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Others
  • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Amniotic Membrane Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Amniotic Membrane Market: End Use Movement Analysis
• 6.3. Amniotic Membrane Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals
  • 6.5.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Ambulatory Surgical Centers
  • 6.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Specialty Clinics
  • 6.7.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.8. Research Institutes and Academic Institutes
  • 6.8.1. Research Institutes and Academic Institutes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Amniotic Membrane Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional Amniotic Membrane Market movement analysis
• 7.3. Amniotic Membrane Market: Regional Estimates & Trend Analysis by Product, Application & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait Amniotic Membrane Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. Alliqua BioMedical Inc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. Amnio Technology, LLC.
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Applied Biologics LLC
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Human Regenerative Technologies, LLC
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. DermaSciences
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Katena Products, Inc.
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. MiMedx Group Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Skye Biologics, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Amniox Medical Inc.
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. Integra LifeSciences
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives

관련자료